Sleep-Wake Disorders

What can we learn from sleep in schizophrenia? New research sheds light.

What risk does clomiphene use present to patients?

How does schizophrenia differ between men and women, and what does this mean for developing treatment strategies?

Test your knowledge on the latest research in sleep issues and schizophrenia.

From research updates on at-home ketamine use to the effects of comorbid depression and anxiety on insomnia treatment, here are highlights from the week in Psychiatric Times.

New research finds depressive and anxiety symptoms impact effectiveness of cognitive behavioral therapy for insomnia.

From obesity and metabolism in first-episode MDD to psychiatrist liability and suicide, here are highlights from the week in Psychiatric Times.

New positive data was recently released from 5 in vitro studies investigating the potential for drug-drug interaction of mazindol.

From adherence in addiction recovery treatment to the relationship between social media use and youth mental health, here are highlights from the week in Psychiatric Times.

Although more than 90% of children had at least 1 caregiver-reported sleep problem, only 20% had a clinician-documented sleep problem.

Researchers investigated relationships between sleep problems, suicidal ideation, and psychopathology in patients with first-episode psychosis.

Treatment is now the first and only once-at-bedtime oxybate to be approved by the FDA for individuals with narcolepsy.

Richard K. Bogan, MD, FCCP, FAASM, and Asim Roy, MD, share take-home messages for the management of narcolepsy.

Experts in sleep medicine present a case of a 29-year-old male with EDS, vivid dreams, sleep paralysis, and adult ADD, and share their initial impressions.

Let's discuss the importance of a sleep conducive environment.

Sleep experts present a case of an 18-year-old female preparing for college with EDS and cataplexy, and share their approach to treatment.

Drs Asim Roy and Richard K. Bogan discuss remaining unmet needs in the therapeutic landscape for narcolepsy.

Richard K. Bogan, MD, FCCP, FAASM, and Asim Roy, MD, comment on the evolving treatment landscape for narcolepsy and patient selection of FDA-approved agents: solriamfetol, pitolisant, and lower-sodium oxybate.

Experts in sleep medicine share insight on initiating treatment for the management of narcolepsy.

Sleep experts comment on diagnostic criteria for narcolepsy, factors that may lead to misdiagnosis, and the impact of the condition on a patient’s quality of life.

Richard K. Bogan, MD, FCCP, FAASM, and Asim Roy, MD, provide an overview of the pathophysiology of narcolepsy and the role of orexin in regulating the sleep/wakefulness cycle.

Researchers investigated sleep disturbances in individuals at ultra-high risk of psychosis.

The value of a good night's sleep...

Sleep and suicide: researchers performed a systematic review and meta-analysis of objective sleep markers of suicidal behaviors in patients with psychiatric disorders.